Veracyte, Inc. (NASDAQ: VCYT) announced the acquisition of Convergent Genomics, adding the UroAmp urinary tumor DNA (utDNA) testing platform to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions